AAS
BCRX icon

Avantax Advisory Services’s BioCryst Pharmaceuticals BCRX Stock Holding History

Avantax Advisory Services’s Portfolio BCRX Stock Details BCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-25,000
Closed -$86K – 966
2020
Q3 		$86K Buy
+25,000
New +$86K ﹤0.01% 1313